Allergy & Asthma Associates of Maine | Lewiston

Allergy & Asthma Associates of Maine | Lewiston is a full-service Allergy, Asthma, and Immunology practice in Lewiston, ME. The clinic serves patients across the greater Portland area, treating individuals from infancy through adulthood. The practice specializes in environmental allergies triggered by pollen or dust, food allergies involving immune reactions to specific proteins, medication allergies, asthma characterized by narrowed airways, and insect allergies caused by venom or saliva. Providers at this location bring over 30 years of combined experience in treating allergy, asthma, and immunological conditions. The practice accepts all forms of insurance, including Maine Medicaid and Medicare.

The clinical team includes physicians Ivan Cardona, MD, Jon Musmand, MD, Russell Behmer, MD, and Andrew Parker, MD, as well as Chelsea Michaud, DO, and nurse practitioners Denise Viekman, FNP, and Meryl Scichilone, FNP. The practice follows strict national and international guideline-based criteria when evaluating conditions such as Mast Cell Activation Syndrome, recommending treatment only when those specific criteria are met. The clinic does not offer testing or treatment for food intolerances or sensitivities, nor does it provide specialized evaluation for Long COVID, directing patients with those concerns to primary care providers or dedicated post-COVID clinics. Support staff include dedicated coordinators for biologics and IVIG assistance, as well as Spanish language support for patients.

The Lewiston office is located at 33r Mollison Way. It sits on Mollison Way, about a quarter mile from the intersection with Main Street and Fair Street. The site is roughly half a mile from Mayer Park and the Lewiston Fire Department Main Street Substation, and about three-quarters of a mile from the Jepson Brook canal.

Allergy & Asthma Associates of Maine | Lewiston provides specialized allergy, asthma, and immunology care in Lewiston, serving patients of all ages with a focus on guideline-based treatment and comprehensive insurance acceptance.